Getinge acquires Ultra Clean Systems Inc.

Getinge recently announced the acquisition of 100% of the shares of Ultra Clean Systems Inc., a leading U.S. manufacturer of ultrasonic cleaning technologies, used in hospitals and surgery centers to decontaminate surgical instruments.

Ultrasonic cleaning is an integral part of best practices to reprocess instruments, especially the most complex ones used for robotic surgery, in order to minimize the risk of hospital acquired infections.

“With the addition of Ultra Clean’s expertise and technology, we significantly expand our offering to sterile reprocessing departments in North America, which now contains a complete range of process equipment, consumables and IT solutions,” says Stéphane Le Roy, president surgical workflows at Getinge. “Getinge’s global sales reach will be a great platform to accelerate the adoption of Ultra Clean’s technologies”.

Ultra Clean Systems Inc. is located near Tampa, Florida, US, and generated an annual revenue of SEK 90 M in 2022. For nearly a decade, Getinge has been the exclusive distributor of Ultra Clean Systems’ offering in North America. Through the vertical integration Getinge will ensure optimal service continuity for the hundreds of units installed in the United States.

Becky Cale, president, and O’Brien Cale, CEO and founder of Ultra Clean Systems adds, “In supporting Getinge to realize its strategic ambition, Ultra Clean Systems is rightly being recognized for its expertise in Ultra Sonic cleaning technology. We can feel an immense pride knowing that our customers will continue to benefit from the quality products that Ultra Clean Systems has been known for.”

Getinge acquires 100% of the shares of Ultra Clean Systems Inc. for SEK 170 M (USD 16 M) in cash. Getinge expects no material integration costs in 2023.

The acquisition is not expected to have a material impact on Getinge’s operating profit and earnings per share as of 2023.

For more information about Ultra Clean Inc.: https://ultracleansystems.com/

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X